William Long

Sr. Director Of Product Marketing at Pulmonx

William Long has a diverse work experience in the field of product marketing and management. William is currently employed as the Sr. Director of Product Marketing at Pulmonx Corporation since April 2023. Prior to this role, they served as the Director of Product Marketing at the same company from August 2020 to April 2023.

Before joining Pulmonx Corporation, William worked at Intuitive Surgical for a significant period. Their roles at Intuitive Surgical include Group Product Manager for Endoluminal from April 2017 to August 2020, Group Marketing Manager for Thoracic Surgery from July 2015 to March 2017, Senior Marketing Manager for Thoracic Surgery from January 2014 to July 2015, and Marketing Manager for Thoracic Surgery from July 2011 to January 2014. In these positions, they were responsible for various marketing activities and played a key role in the launch of the first robotic stapling device for thoracic procedures.

William also gained experience through an internship at Intuitive Surgical in 2010, where they served as an MBA Marketing Intern.

At the start of their career, William worked at AbelsonTaylor, Inc. William held positions such as Senior Account Executive for New Business from April 2009 to August 2009, Account Executive for New Business from March 2007 to March 2009, Assistant Account Executive for New Business from September 2005 to February 2007, and Account Coordinator from January 2005 to August 2005.

Overall, William Long has a strong background in product marketing and management, with notable contributions to the field of robotic-assisted thoracic surgery.

William Long completed their Bachelor of Arts degree in Public Policy with Honors at the University of Chicago from 1999 to 2003. William then pursued further education at The University of Chicago Booth School of Business, where they earned an MBA with Honors from 2009 to 2011. Their MBA program focused on Strategic Management, Accounting, and Entrepreneurship.

Location

San Francisco, United States

Links


Org chart


Teams


Offices


Pulmonx

2 followers

Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1


Industries

Employees

201-500

Links